Business & regional news

Apr 30, 2024

CRISTAL study published in The Lancet Diabetes & Endocrinology shows promising outcomes for pregnant women living with type 1 diabetes

Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy. Medtronic, a global leader in healthcare technology, today announced the results of...
- Diabetes
Apr 29, 2024

April 29 proclaimed ‘Medtronic Day’ in Minnesota

Honorary day celebrates Medtronic roots, 75th anniversary year
- Photos 6
Apr 24, 2024

New randomized controlled data from VenaSeal Spectrum Program reinforces evidence that VenaSeal™ closure system is safe and effective
- Peripheral Vascular Health
Apr 23, 2024

Medtronic welcomes compelling evidence from Europe and Asia that reveal advanced hybrid closed loop systems are more cost-effective than standard management of type 1 diabetes

Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems. Medtronic, a global leader in healthcare technology,...
- Diabetes
Apr 22, 2024

Medtronic launches the Avalus Ultra™ valve engineered for ease of use at implant and lifetime patient management

Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus™ valve
- Cardiac Surgery

Show per page